Adding antiplatelet therapy to anticoagulation does not cut stroke risk but raises major bleeding
Combined Anticoagulant and Antiplatelet Therapy Increases Bleeding Risk
This meta-analysis of 14,884 patients with recent ischemic stroke, nonvalvular atrial fibrillation, and large artery atherosclerosis found t…
Combining two types of blood thinners may increase bleeding risks without reducing the chance of a second stroke in patients with certain he…
Postoperative atrial fibrillation increases long-term thromboembolic risk following CABG and isolated valve surgery
Atrial Fibrillation After Heart Surgery Linked to Higher Blood Clot Risk
This meta-analysis of observational studies indicates that postoperative atrial fibrillation (POAF) is associated with increased long-term t…
New analysis suggests that patients who develop atrial fibrillation after heart surgery face a higher risk of long-term blood clots.
DOACs associated with lower risks of recurrent ICH, ischemic stroke, and mortality in atrial fibrillation
Trial Shows Direct Oral Anticoagulants Reduce Risks for Atrial Fibrillation
This meta-analysis evaluates the efficacy of direct oral anticoagulants (DOACs) compared to vitamin K antagonists (VKAs) in patients with at…
New data suggests that direct oral anticoagulants may lower the risk of stroke and bleeding for patients with atrial fibrillation.
Edoxaban patients with CAD/PAD show higher stroke, ACS, and cardiovascular death rates
Patients with heart disease face higher risks on edoxaban
This prospective cohort study of 13,164 patients with atrial fibrillation (AF) receiving edoxaban in routine care found significantly higher…
New data shows that patients with atrial fibrillation and existing heart disease may face higher rates of stroke and bleeding while on edoxa…
DOAC plus calcium-channel blocker co-use raises major bleeding risk 21% in atrial fibrillation
Combining certain heart medications may increase risk of major bleeding
This meta-analysis of 408,276 patients with atrial fibrillation and elevated thromboembolic risk found that co-use of direct oral anticoagul…
Patients with atrial fibrillation taking both a specific blood thinner and a calcium channel blocker may face a higher risk of serious bleed…
No difference in cardioversion success between RBW and BTE waveforms for atrial fibrillation
Trial Shows No Difference Between Two Shock Waveforms for Atrial Fibrillation
This randomized trial of 546 adult patients with symptomatic atrial fibrillation found no significant difference in successful direct curren…
A clinical trial found that two different types of electrical shock waveforms are equally effective at treating atrial fibrillation.
CHAT-AF-S conversational AI protocol aims to improve quality of life in atrial fibrillation
Trial Plans to Test AI Chatbots for Atrial Fibrillation Patients
This randomised controlled trial protocol will enroll 480 adults with atrial fibrillation to test whether a conversational AI self-managemen…
A new clinical trial plans to see if conversational artificial intelligence can improve the quality of life for adults living with atrial fi…
AI-enabled devices with nurse-led screening show good diagnostic accuracy for opportunistic atrial fibrillation detection
AI tools and nurses help find heart rhythm problems early
This mini review explores the use of AI-enabled single-lead ECG and photoplethysmography for atrial fibrillation screening by non-physician …
New screening methods using AI and nurse-led checkups could catch atrial fibrillation sooner to lower stroke risks in community settings.
Perioperative dexmedetomidine reduces postoperative atrial fibrillation and delirium risk in adult cardiac surgery patients
Dexmedetomidine May Lower Risk of Heart Rhythms and Delirium
This meta-analysis of randomized controlled trials involving 4063 patients found that perioperative dexmedetomidine significantly reduced th…
A new review suggests that dexmedetomidine may lower the risk of heart rhythm issues and delirium for adults undergoing cardiac surgery.
NOAC monotherapy reduces net adverse clinical events in older patients with atrial fibrillation and stents
NOAC Monotherapy Shows Lower Risk for Older Patients with Atrial Fibrillation
This post hoc analysis investigated the impact of NOAC monotherapy versus combination therapy with clopidogrel in patients with atrial fibri…
Patients over 75 with atrial fibrillation and drug-eluting stents may have fewer adverse events when taking a single NOAC instead of combina…
CCTA imaging biomarkers provide multidimensional cardiovascular risk stratification for coronary heart disease and atrial fibrillation
New imaging markers help identify high risk heart disease
This narrative review synthesizes evidence on CCTA imaging biomarkers, including plaque characteristics, FFR-CT, EAT, PCAT, and hepatic stea…
Advanced imaging can now spot specific signs of heart inflammation and plaque growth to better predict serious heart events.
Thromboembolic events cost 2.5-fold more per event than bleeding after high-risk endoscopy
High Risk Endoscopy Procedures Linked to Bleeding in Patients
This retrospective cohort study of 2,486 adults on DOAC or warfarin undergoing high-risk endoscopy found a 22.9% bleeding rate at 90 days an…
Patients with atrial fibrillation undergoing high-risk endoscopy face significant risks of bleeding and stroke, which can lead to high medic…